Price Chart

Executive Summary

Argus Research issued a rare double downgrade on May 11, 2026, moving the stock from Buy to Hold with no price target assigned. The firm has a 54% accuracy rate on 339 calls and an average return of 3.7%, placing it in the middle of the pack. Consensus remains heavily bullish: 20 of 33 analysts rate it Buy (61%), 13 Hold (39%), and zero Sell. The mean price target of $245.38 implies 21.7% upside from the current $201.61. Argus is now the most bearish firm on the street, with its Hold rating below the consensus average. Momentum is mixed: EPS estimates for the current quarter have been revised down 10 times in the past 30 days, but full-year estimates have seen 9 upward revisions. Insider and congressional trades show no activity, while institutional flows are divergent — FMR trimmed 31.3% but Morgan Stanley added 38.6%. Short interest is elevated at 69.3% of off-exchange volume, suggesting bearish positioning. The double downgrade from a mid-tier firm is a contrarian signal against a bullish consensus, but the lack of a price target and the firm's average track record reduce conviction. Traders should treat this as a cautionary note rather than a full reversal signal.

Impact Score

Consensus & Targets

Consensus is heavily bullish: 8 Strong Buy, 12 Buy, 13 Hold, 0 Sell, 0 Strong Sell — total 33 analysts. That's 61% Buy/Strong Buy and 39% Hold. No analyst recommends selling. Argus's Hold is now the most bearish rating on the street, below the consensus average.

Current price: $201.61. Mean target: $245.38 (implied upside +21.7%). Median target: $250. High: $270 (+33.9%). Low: $200 (-0.8%). Argus did not provide a price target, so its view is below the low end of the consensus range. The mean target is based on 24 analysts.

Recent Analyst Activity

In the past 30 days, there has been 1 downgrade (Argus) and 0 upgrades. EPS revisions for the current quarter (0q) show 10 downward revisions vs 1 upward in the last 30 days, with the average estimate falling from $1.668 to $1.638. However, full-year (0y) estimates have seen 9 upward revisions vs 4 downward, and the average has ticked up slightly from $7.237 to $7.241. Next quarter (+1q) shows 6 upward vs 5 downward revisions. The trend is mixed — near-term estimates are being cut, but longer-term estimates are being raised.

Firm Track Record — Argus Research

Argus Research accuracy: 54% on 339 calls | avg return: 3.7%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.

Argus Research has a 54% accuracy rate on 339 calls with an average return of 3.7%. This places it in the middle of the pack. Top-tier firms like RBC Capital, Baird, CIBC, Truist, Goldman Sachs, Stifel, and Morgan Stanley all have 100% accuracy on limited samples (2-4 calls each). The worst performers are Citigroup (0% on 2 calls, avg return -2.6%) and JP Morgan (33% on 3 calls, avg return -3.1%). Argus's downgrade is a contrarian call against consensus but from a firm with only average predictive power.

Earnings Estimates

Cross-Platform Signals

Insider trades: none reported. Congressional trades: none. Institutional activity is mixed: FMR LLC trimmed 31.3% ($939M position) but also added 35.3% ($1.48B) in a separate fund, suggesting rotation. Morgan Stanley added 38.6% ($1.13B). Norges Bank initiated a new $617M position. Renaissance Technologies more than quintupled its position (+465%, $91M). Short interest is elevated at 69.3% of off-exchange volume, indicating significant bearish positioning. The divergence between institutional buying (Morgan Stanley, Norges, Renaissance) and short interest creates a tug-of-war, reducing conviction in the downgrade signal.

Investment Themes

Documents Analyzed

Report based on filing metadata.

US Market Status